{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-001980","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.585117+00:00","generated_at":"2026-06-25T14:57:36.368970+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Entera Bio appoints Miranda Toledano as CFO, CBO, and Head of Corp Strategy; prior CFO Ratan departs","bullets":["Miranda Toledano appointed Chief Business Officer, CFO, and Head of Corporate Strategy effective May 16, 2022.","Toledano loses independence; no longer serves on Compensation or Audit Committees; vacancies to be filled.","Annual employer cost of $350,000; options for 500k shares at $2.02, vesting over 4 years (25% at year 1).","Prior CFO Ramesh Ratan no longer with company; Dana Yaacov-Garbeli remains as principal accounting officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-001980","json":"https://secwatch.observer/filing/0001178913-22-001980.json","markdown":"https://secwatch.observer/filing/0001178913-22-001980.md","text":"https://secwatch.observer/filing/0001178913-22-001980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322001980/0001178913-22-001980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322001980/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T14:57:36.368970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65ad4ccf06","claim":"Miranda J. Toledano was appointed as Chief Business Officer, Chief Financial Officer and Head of Corporate Strategy at Entera Bio Ltd..","evidence_excerpt":"appointed Ms. Miranda J. Toledano, one of the Company’s existing directors, to serve as the Company’s Chief Business Officer, Chief Financial Officer and Head of Corporate Strategy, effective as of May 16, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322001980/0001178913-22-001980-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Business Officer, Chief Financial Officer and Head of Corporate Strategy"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}